In contrast, the MDA-MB cell line, characterized by its lack of estrogen receptor expression (ER-), is primarily employed for studying more aggressive breast cancer behaviours, such as metastasis and drug resistance. This evidence concerns the gene ESR1 and breast carcinoma.